AI assistant
Sending…
Health Catalyst, Inc. — Director's Dealing 2025
Mar 4, 2025
33681_dirs_2025-03-04_8ceb8a11-de8f-49f5-9add-f5c128ce688c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2025-03-03
Reporting Person: Alger Jason (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-03 | Common Stock | F | 7304.00 | $4.5771 | Disposed | 272358.00 | Direct |
Footnotes
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
More from Health Catalyst, Inc.
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 20
Regulatory Filings
2026
Feb 18
Regulatory Filings
2026
Jan 23